Cunningham; James J.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Cunningham; James J..The latest application filed is for "intraocular implant with high loading of a prostamide".

Company Profile

2.13.12

Cunningham; James J. - San Clemente CA
Cunningham; James J. - Wayne PA
Cunningham; James J. - Devon PA
Cunningham; James J. - Chicago IL
Cunningham, James J. - Dover FL
Cunningham; James J. - Hamilton Square NJ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Intraocular Implant With High Loading Of A Prostamide App 20220023095 - Ghebremeskel; Alazar N. ; et al.	2022-01-27
Rna Interference Mediated Inhibition Of Catenin (cadherin-associated Protein), Beta 1 (ctnnb1) Gene Expression Using Short Inter App 20190330639 - Brown; Duncan ; et al.	2019-10-31
RNA interference mediated inhibition of catenin (cadherin-associated protein), beta 1 (CTNNB1) gene expression using short interfering nucleic acid (siNA) Grant 10,246,714 - Brown , et al.	2019-04-02
Rna Interference Mediated Inhibition Of Catenin (cadherin-associated Protein), Beta 1 (ctnnb1) Gene Expression Using Short Interfering Nucleic Acid (sina) App 20180030454 - Brown; Duncan ; et al.	2018-02-01
RNA interference mediated inhibition of catenin (cadherin-associated protein), beta 1 (CTNNB1) gene expression using short interfering nucleic acid (siNA) Grant 9,850,491 - Brown , et al. December 26, 2	2017-12-26
Rna Interference Mediated Inhibition Of Catenin (cadherin-associated Protein), Beta 1 (ctnnb1) Gene Expression Using Short Interfering Nucleic Acid (sina) App 20170029824 - Brown; Duncan ; et al.	2017-02-02
RNA interference mediated inhibition of catenin (cadherin-associated protein), beta 1 (CTNNB1) gene expression using short interfering nucleic acid (SINA) Grant 9,447,420 - Brown , et al. September 20, 2	2016-09-20
RNA interference mediated inhibition of gene expression using short interfering nucleic acids (siNA) Grant 9,260,471 - Cancilla , et al. February 16, 2	2016-02-16
Rna Interference Mediated Inhibition Of Catenin (cadherin-associated Protein), Beta 1 (ctnnb1) Gene Expression Using Short Interfering Nucleic Acid (sina) App 20140343126 - Brown; Duncan ; et al.	2014-11-20
RNA interference mediated inhibition of catenin (cadherin-associated protein), beta 1 (CTNNB1) gene expression using short interfering nucleic acid (siNA) Grant 8,835,623 - Brown , et al. September 16, 2	2014-09-16
RNA Interference Mediated Inhibition of Catenin (Cadherin-Associated Protein), Beta 1 (CTNNB1) Gene Expression Using Short Interfering Nucleic Acid (siNA) App 20130324588 - Brown; Duncan ; et al.	2013-12-05
RNA interference mediated inhibition of catenin (cadherin-associated protein), beta 1 (CTNNB1) gene expression using short interfering nucleic acid (siNA) Grant 8,518,907 - Brown , et al. August 27, 2	2013-08-27
RNA Interference Mediated Inhibition of Catenin (Cadherin-Associated Protein), Beta 1 (CTNNB1) Gene Expression Using Short Interfering Nucleic Acid (siNA) App 20130137752 - Brown; Duncan ; et al.	2013-05-30
Combination therapy including a matrix metalloproteinase inhibitor and an antineoplastic agent Grant 6,916,800 - McKearn , et al. July 12, 2	2005-07-12
Combination therapy including a matrix metalloproteinase inhibitor and an antineoplastic agent App 20050058725 - McKearn, John P. ; et al.	2005-03-17
Method of using a matrix metalloproteinase inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia Grant 6,858,598 - McKearn , et al. February 22, 2	2005-02-22
Combination therapy including a cyclooxygenase-2 inhibitor and an antineoplastic agent App 20050037090 - McKearn, John P. ; et al.	2005-02-17
Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia Grant 6,833,373 - McKearn , et al. December 21, 2	2004-12-21
Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia App 20040234624 - McKearn, John P. ; et al.	2004-11-25
Method of using an integrin antagonist and radiation therapy as combination therapy in the treatment of neoplasia Grant 6,689,787 - McKearn , et al. February 10, 2	2004-02-10
Post operative knee flexer App 20030171196 - Cunningham, James J.	2003-09-11
Panel mounted cooling system Grant 5,657,641 - Cunningham , et al. August 19, 1	1997-08-19

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.